Rising Ocular Infections Demand Early Detection to Prevent Vision Loss, Flinders Research Warns

Two new reviews highlight the blinding potential of ocular syphilis and toxoplasmosis, urging Australian eyecare professionals to maintain a high index of suspicion, particularly in immunocompromised patients.

Rising rates of infectious eye diseases are putting patients at heightened risk of preventable vision loss, prompting leading Australian researchers to issue a clinical alert. Two new reviews led by Flinders University highlight the diagnostic challenges of ocular syphilis and ocular toxoplasmosis, emphasising that early recognition and prompt intervention are critical to saving sight.

The Clinical Challenge

Both conditions are notorious for mimicking other ocular pathologies, creating significant diagnostic pitfalls that can delay sight-saving treatment. Common presenting symptoms include blurred vision, new-onset floaters, ocular inflammation, and sudden changes in visual acuity. 

The research points to a concerning global resurgence of syphilis, with cases rising from approximately eight million in 1990 to 14 million in 2019. Concurrently, eye specialists are reporting a corresponding increase in ocular syphilis, a potentially blinding complication that occurs when the bacterium affects the eye.

Meanwhile, ocular toxoplasmosis remains the leading global cause of infectious inflammation at the back of the eye. Caused by the Toxoplasma gondii parasite which infects up to 30 per cent of the global population. The disease can remain dormant for years before reactivating to cause severe retinal damage.

The Misdiagnosis Risk

The reviews underscore the severe consequences of delayed diagnosis. Data indicates that visual outcomes in ocular syphilis worsen significantly when treatment is postponed. Perhaps most alarmingly for clinicians, more than half of reported ocular toxoplasmosis cases in immunocompromised patients were initially misdiagnosed, substantially increasing the risk of irreversible complications.

Senior author and internationally recognised ophthalmologist Professor Justine Smith, from the Flinders Health and Medical Research Institute (FHMRI) Eye & Vision, stressed that understanding the ocular manifestations of these systemic infections is paramount for frontline eyecare providers.

"The encouraging message is that many people can retain good vision if these infections are recognised and treated early," Professor Smith said. "Don't ignore a sudden change in your vision. Although there can be many causes, infectious eye diseases are often treatable, and the best outcomes usually come when they are diagnosed early."

Co-author Associate Professor João Furtado, from the University of São Paulo, noted that both public and professional awareness are key to mitigating avoidable sight loss. 

"People often assume blurred vision, floaters or other sudden visual changes will go away on their own, but these symptoms can sometimes signal a serious eye infection," Associate Professor Furtado said. "Prompt assessment is essential because delays can significantly increase the risk of permanent vision loss."

At-Risk Populations

The researchers specifically flagged patients with weakened immune systems as requiring heightened clinical vigilance. This includes individuals living with HIV, those undergoing cancer treatment, patients on immunosuppressive therapies, and post-organ transplant recipients. In these cohorts, ocular infections can progress more aggressively and inflict greater structural damage to the retina.

Takeaways for Practice

For Australian optometrists and ophthalmologists, the findings reinforce the importance of comprehensive case histories, including systemic health and immune status, when patients present with unexplained posterior segment inflammation or acute visual changes. 

Key clinical takeaways include:

• Maintain a high index of suspicion for infectious aetiologies in cases of atypical or recalcitrant uveitis.
• Scrutinise systemic health histories, particularly noting immunocompromised status or recent systemic infections.
• Adopt a low threshold for referral and collaborative management with medical retina specialists or infectious disease physicians when infectious posterior uveitis is suspected.
• Educate patients to seek immediate assessment for sudden visual changes, rather than adopting a "wait and see" approach.

The reviews, Ocular toxoplasmosis in the immunocompromised patient and Putative mechanisms of ocular inflammation in syphilis, were supported by the National Health and Medical Research Council (NHMRC) and Australian Vision Research, underscoring the local relevance of these critical global findings.